Skip to main content
Premium Trial:

Request an Annual Quote

Curve Biosciences: Nathan Hunkapiller, Chuba Oyolu

Curve Biosciences, a company leveraging its Chronic Disease Tissue Atlas to develop liquid biopsy tests and other products for chronic disease care, this week announced the appointment of Nathan Hunkapiller as CSO and Chuba Oyolu as chief technology officer.

Hunkapiller joined the company last year as a scientific adviser. Prior to that he was senior VP of R&D at Grail. Earlier, he was VP of R&D at Natera. He holds a PhD in biomedical sciences from the University of California, San Francisco and a bachelor's degree in biology from Stanford University.

Oyolu joined Curve last year in a technical advisory role. He was previously founding scientist and senior site director at Counsyl. He holds a PhD in bioengineering from Stanford University and a bachelor's degree in electrical engineering from the University of Pittsburgh.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.